O-phosphonatomethylcholine, its analogues, alkyl esters, and their biological activity

Journal of Medicinal Chemistry

Volumn 44, Issue 25, 2001, Pages 4462-4467

  Holy A ^a   Otova B ^a,b   Budesky M ^a   Emerson, D ^c   Wiles, M E ^c  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ALKANE DERIVATIVE; AMMONIUM DERIVATIVE; ANTINEOPLASTIC AGENT; DIMETHYLAMINE; ESTER DERIVATIVE; METHYL IODIDE; METHYLPHOSPHONIC ACID; MILTEFOSINE; MORPHOLINE; MORPHOLINE DERIVATIVE; O PHOSPHONATOMETHYLCHOLINE DERIVATIVE; PHOSPHORYLCHOLINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SILANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL REACTION; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LYMPHOMA; MALE; NONHUMAN; RAT; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CHOLINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; PHOSPHONIC ACIDS; PHOSPHORYLCHOLINE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035818891     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010974h     Document Type: Article

References (43)

1. Biochemical pharmacology of acyclic nucleotide analogues
2. Metabolism of 1-(S)-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine (HPMPC) in Human Embryonic Lung Cells
3. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
4. Phosphonylmethyl ethers of nucleosides and their acyclic analogues
5. Isopolar phosphorus-modified nucleotide analogues
6. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: A review of their pharmacology and clinical potential in the treatment of viral infections
7. Towards an effective chemotherapy of virus infections: Therapeutic potential of cidofovir [(S)-l-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, HPMPC] for the treatment of DNA virus infections
8. Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis
9. Topical and intralesional cidofovir: A review of pharmacology and therapeutic effects
10. Cidofovir. Review of current and potential clinical uses
11. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]
12. Progressive multifocal leukoencephalopathy
13. Cidofovir (CDF) for the treatment of EBV-infection in allogeneic stem cell transplantation
14. Systemic cidofovir in papillomatosis
15. Topical cidofovir for bowenoid papulosis in an HIV-infected patient
16. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children
17. Effect of the anti-neoplastic agents edelfosine (ET18-0CH3), ilmofosine (BM 41.440) and the hexadecylphosphocholine analogues D-20133 and D-21266 on histamine release from isolated rat mast cells
18. Metabolism of ether phospholipids and analogs in neoplastic cells
19. Hexadecylphosphocholine: A new and selective antitumor drug
20. The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferation
21. Effects of hexadecylphosphocholine on cellular function
22. Hexadecylphosphocholine differs from conventional cytostatic agents
23. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study
24. Molecular and cellular effects of hexadecylphosphocholine (Miltefosine) in human myeloid leukaemic cell lines
25. Alkylphosphocholines: A new class of membrane-active anticancer agents
26. Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction
27. Cytotoxic etherphospholipid analogues
28. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo
29. Erucylphosphocholine, a novel antineoplastic ether lipid, blocks growth and induces apoptosis in brain tumor cell lines in vitro
30. Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines
31. Erucylphosphocholine is the prototype of i.v. injectable alkylphosphocholines
32. Synthesis of enantiomeric N-(2-phosphonomethoxypropyl) derivatives of purine and pyrimidine bases. 1. The stepwise approach
33. Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base
34. An improved synthesis of 6-(O-Phosphorylcholine)hydroxyhexanoic acid
35. Preparation of 9-(2-phosphonomethoxyethyl)adenine esters as potential prodrugs
36. Synthesis of some "abbreviated" NAD(+) analogues
37. Antitumor activity of novel purine acyclic nucleotide analogs PMEA and PMEDAP
38. 9-[2(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP) - A potential drug against hematological malignancies - Induces apoptosis
39. Miltefosine - The long-awaited therapy for visceral leishmaniasis?
40. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis
41. Oral treatment of visceral leishmaniasis with miltefosine